134 related articles for article (PubMed ID: 38554421)
1. Prolonged Intake of Luvos Healing Earth does not alter the Composition of the Gut Microbiota in Patients with Diarrhea-predominant Irritable Bowel Syndrome and Healthy Controls.
Vasapolli R; Krikonas S; Macke L; Gravdal K; Kirste KH; Casén C; Storr M; Malfertheiner P; Schulz C
J Gastrointestin Liver Dis; 2024 Mar; 33(1):30-36. PubMed ID: 38554421
[TBL] [Abstract][Full Text] [Related]
2. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
Li Y; Hong G; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
Pharmacol Res; 2020 Sep; 159():104936. PubMed ID: 32470562
[TBL] [Abstract][Full Text] [Related]
3. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
Chen J; Lan H; Li C; Xie Y; Cheng X; Xia R; Ke C; Liang X
J Appl Microbiol; 2024 Jun; 135(6):. PubMed ID: 38849305
[TBL] [Abstract][Full Text] [Related]
4. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
[TBL] [Abstract][Full Text] [Related]
5. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
Wei W; Wang HF; Zhang Y; Zhang YL; Niu BY; Yao SK
World J Gastroenterol; 2020 Dec; 26(45):7153-7172. PubMed ID: 33362374
[TBL] [Abstract][Full Text] [Related]
6. Gut Bacterial Dysbiosis in Irritable Bowel Syndrome: a Case-Control Study and a Cross-Cohort Analysis Using Publicly Available Data Sets.
Kim GH; Lee K; Shim JO
Microbiol Spectr; 2023 Feb; 11(1):e0212522. PubMed ID: 36652592
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbial Dysbiosis in the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Case-Control Studies.
Wang L; Alammar N; Singh R; Nanavati J; Song Y; Chaudhary R; Mullin GE
J Acad Nutr Diet; 2020 Apr; 120(4):565-586. PubMed ID: 31473156
[TBL] [Abstract][Full Text] [Related]
8. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
[TBL] [Abstract][Full Text] [Related]
9. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
[TBL] [Abstract][Full Text] [Related]
10. Increased Ileal Immunoglobulin A Production and Immunoglobulin A-Coated Bacteria in Diarrhea-Predominant Irritable Bowel Syndrome.
Liu Y; Yuan X; Li L; Lin L; Zuo X; Cong Y; Li Y
Clin Transl Gastroenterol; 2020 Mar; 11(3):e00146. PubMed ID: 32352710
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID).
Vasapolli R; Schulz C; Schweden M; Casèn C; Kirubakaran GT; Kirste KH; Macke L; Link A; Schütte K; Malfertheiner P
Eur J Clin Invest; 2021 Dec; 51(12):e13666. PubMed ID: 34390492
[TBL] [Abstract][Full Text] [Related]
12. The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.
Zhan K; Wu H; Xu Y; Rao K; Zheng H; Qin S; Yang Y; Jia R; Chen W; Huang S
mSystems; 2024 Mar; 9(3):e0129923. PubMed ID: 38329942
[TBL] [Abstract][Full Text] [Related]
13. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
[TBL] [Abstract][Full Text] [Related]
14. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
15. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome.
Mei L; Zhou J; Su Y; Mao K; Wu J; Zhu C; He L; Cui Y
BMC Gastroenterol; 2021 Mar; 21(1):105. PubMed ID: 33663411
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome.
Su Q; Tun HM; Liu Q; Yeoh YK; Mak JWY; Chan FK; Ng SC
Gut Microbes; 2023; 15(1):2157697. PubMed ID: 36573834
[TBL] [Abstract][Full Text] [Related]
17. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation.
Mazzawi T; Lied GA; Sangnes DA; El-Salhy M; Hov JR; Gilja OH; Hatlebakk JG; Hausken T
PLoS One; 2018; 13(11):e0194904. PubMed ID: 30427836
[TBL] [Abstract][Full Text] [Related]
18. Methanogen Levels Are Significantly Associated with Fecal Microbiota Composition and Alpha Diversity in Healthy Adults and Irritable Bowel Syndrome Patients.
Wang T; van Dijk L; Rijnaarts I; Hermes GDA; de Roos NM; Witteman BJM; de Wit NJW; Govers C; Smidt H; Zoetendal EG
Microbiol Spectr; 2022 Dec; 10(6):e0165322. PubMed ID: 36321894
[TBL] [Abstract][Full Text] [Related]
19. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
[TBL] [Abstract][Full Text] [Related]
20. Baseline gut microbial profiles are associated with the efficacy of
Hong G; Li Y; Yang M; Li G; Jin Y; Xiong H; Qian W; Hou X
Scand J Gastroenterol; 2023 Apr; 58(4):339-348. PubMed ID: 36281578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]